_id
69171f653c536f8df23167fd
Ticker
TLSIW
Name
TriSalus Life Sciences Inc.
Exchange
NASDAQ
Address
6272 West 91st Avenue, Westminster, CO, United States, 80031
Country
USA
Sector
Industry
Currency
USD
Website
https://trisaluslifesci.com
Description
TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers. It offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial for treating locally advanced pancreatic cancer. The company is also developing nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma, intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and pancreatic cancer. It serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. The company was founded in 2009 and is headquartered in Westminster, Colorado.
Last Close
1.38
Volume
2666
Current Price
1.367
Change
0.52
Last Updated
2026-01-07T13:13:19.692Z
Image
https://logo.clearbit.com/trisaluslifesci.com
Ipo Date
2023-08-11T00:00:00.000Z
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
11566000
Cost Of Revenue
1906000
Gross Profit
9660000
Operating Expenses
20580000
Operating Income
-9014000
Interest Expense
1460000
Pretax Income
-10806000
Net Income
-10811000
Eps
-0.21669109076514523
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
-
EBITDA
-
Operating Margin
-77.93532768459276
Total Other Income Expense Net
-502000
Cash
22687000
Short Term Investments
-
Receivables
5000000
Inventories
3276000
Total Current Assets
33328000
Property Plant Equipment
2716000
Total Assets
36463000
Payables
3784000
Short Term Debt
-
Long Term Debt
32764000
Total Liabilities
63188000
Equity
-26725000
Bs_currency_symbol
USD
Depreciation
163000
Change In Working Capital
2387000
Cash From Operations
-3709000
Capital Expenditures
216000
Cash From Investing
-
Cash From Financing
82000
Net Change In Cash
-3803000
Cf_currency_symbol
USD
PE
-
PB
-2.5519702800000004
ROE
40.45275958840037
ROA
-29.649233469544466
FCF
-3925000
Fcf Percent
-0.33935673525851634
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
0.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.8
Garp Investing Score
2.5
Growth Investing Score
2.5
Momentum Investing Score
4
Net Net Investing Score
0
Quality Investing Score
3
Value Investing Score
4.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
11566000
Quarters > 0 > income Statement > cost Of Revenue
1906000
Quarters > 0 > income Statement > gross Profit
9660000
Quarters > 0 > income Statement > operating Expenses
20580000
Quarters > 0 > income Statement > operating Income
-9014000
Quarters > 0 > income Statement > interest Expense
1460000
Quarters > 0 > income Statement > pretax Income
-10806000
Quarters > 0 > income Statement > net Income
-10811000
Quarters > 0 > income Statement > eps
-0.21669109076514523
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
49891299
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-77.93532768459276
Quarters > 0 > income Statement > total Other Income Expense Net
-502000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
22687000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
5000000
Quarters > 0 > balance Sheet > inventories
3276000
Quarters > 0 > balance Sheet > total Current Assets
33328000
Quarters > 0 > balance Sheet > property Plant Equipment
2716000
Quarters > 0 > balance Sheet > total Assets
36463000
Quarters > 0 > balance Sheet > payables
3784000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
32764000
Quarters > 0 > balance Sheet > total Liabilities
63188000
Quarters > 0 > balance Sheet > equity
-26725000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-10811000
Quarters > 0 > cash Flow > depreciation
163000
Quarters > 0 > cash Flow > change In Working Capital
2387000
Quarters > 0 > cash Flow > cash From Operations
-3709000
Quarters > 0 > cash Flow > capital Expenditures
216000
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
82000
Quarters > 0 > cash Flow > net Change In Cash
-3803000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.21669109076514523
Quarters > 0 > ratios > PB
-2.5519702800000004
Quarters > 0 > ratios > ROE
40.45275958840037
Quarters > 0 > ratios > ROA
-29.649233469544466
Quarters > 0 > ratios > FCF
-3925000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.33935673525851634
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
11213000
Quarters > 1 > income Statement > cost Of Revenue
1802000
Quarters > 1 > income Statement > gross Profit
9411000
Quarters > 1 > income Statement > operating Expenses
18545000
Quarters > 1 > income Statement > operating Income
-7332000
Quarters > 1 > income Statement > interest Expense
1423000
Quarters > 1 > income Statement > pretax Income
-8291000
Quarters > 1 > income Statement > net Income
-8288000
Quarters > 1 > income Statement > eps
-0.21820139235551114
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
37983259
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-65.38838847765986
Quarters > 1 > income Statement > total Other Income Expense Net
330000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
26490000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
5571000
Quarters > 1 > balance Sheet > inventories
3807000
Quarters > 1 > balance Sheet > total Current Assets
38084000
Quarters > 1 > balance Sheet > property Plant Equipment
2814000
Quarters > 1 > balance Sheet > total Assets
41317000
Quarters > 1 > balance Sheet > payables
1902000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
32274000
Quarters > 1 > balance Sheet > total Liabilities
60740000
Quarters > 1 > balance Sheet > equity
-19423000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-9002000
Quarters > 1 > cash Flow > depreciation
165000
Quarters > 1 > cash Flow > change In Working Capital
-1388000
Quarters > 1 > cash Flow > cash From Operations
-7320000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
20717000
Quarters > 1 > cash Flow > net Change In Cash
13490000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.21820139235551114
Quarters > 1 > ratios > PB
-2.6732798771044637
Quarters > 1 > ratios > ROE
42.67106008340627
Quarters > 1 > ratios > ROA
-20.059539656799867
Quarters > 1 > ratios > FCF
-7320000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.6528136983858022
Quarters > 1 > health Score
31
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
9167000
Quarters > 2 > income Statement > cost Of Revenue
1495000
Quarters > 2 > income Statement > gross Profit
7672000
Quarters > 2 > income Statement > operating Expenses
16496000
Quarters > 2 > income Statement > operating Income
-7329000
Quarters > 2 > income Statement > interest Expense
1209000
Quarters > 2 > income Statement > pretax Income
-10370000
Quarters > 2 > income Statement > net Income
-10375000
Quarters > 2 > income Statement > eps
-0.3214815157269377
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
32272462
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-79.94982000654521
Quarters > 2 > income Statement > total Other Income Expense Net
-1906000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
13000000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
5453000
Quarters > 2 > balance Sheet > inventories
4162000
Quarters > 2 > balance Sheet > total Current Assets
25096000
Quarters > 2 > balance Sheet > property Plant Equipment
3105000
Quarters > 2 > balance Sheet > total Assets
28625000
Quarters > 2 > balance Sheet > payables
2806000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
31699000
Quarters > 2 > balance Sheet > total Liabilities
62995000
Quarters > 2 > balance Sheet > equity
-34370000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-11087000
Quarters > 2 > cash Flow > depreciation
172000
Quarters > 2 > cash Flow > change In Working Capital
1599000
Quarters > 2 > cash Flow > cash From Operations
-4499000
Quarters > 2 > cash Flow > capital Expenditures
754000
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
9688000
Quarters > 2 > cash Flow > net Change In Cash
4475000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.3214815157269377
Quarters > 2 > ratios > PB
-1.2835744996799534
Quarters > 2 > ratios > ROE
30.186208903113183
Quarters > 2 > ratios > ROA
-36.24454148471616
Quarters > 2 > ratios > FCF
-5253000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.5730337078651685
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
8261000
Quarters > 3 > income Statement > cost Of Revenue
1216000
Quarters > 3 > income Statement > gross Profit
7045000
Quarters > 3 > income Statement > operating Expenses
15841000
Quarters > 3 > income Statement > operating Income
-7580000
Quarters > 3 > income Statement > interest Expense
1068000
Quarters > 3 > income Statement > pretax Income
-10109000
Quarters > 3 > income Statement > net Income
-10108000
Quarters > 3 > income Statement > eps
-0.3231533836601782
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
31279264
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-91.7564459508534
Quarters > 3 > income Statement > total Other Income Expense Net
-1518000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
8525000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
5087000
Quarters > 3 > balance Sheet > inventories
4048000
Quarters > 3 > balance Sheet > total Current Assets
20669000
Quarters > 3 > balance Sheet > property Plant Equipment
2879000
Quarters > 3 > balance Sheet > total Assets
23971000
Quarters > 3 > balance Sheet > payables
2274000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
22084000
Quarters > 3 > balance Sheet > total Liabilities
49865000
Quarters > 3 > balance Sheet > equity
-25894000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-10891000
Quarters > 3 > cash Flow > depreciation
193000
Quarters > 3 > cash Flow > change In Working Capital
467000
Quarters > 3 > cash Flow > cash From Operations
-5707000
Quarters > 3 > cash Flow > capital Expenditures
50000
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
2994000
Quarters > 3 > cash Flow > net Change In Cash
-2763000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.3231533836601782
Quarters > 3 > ratios > PB
-1.651299678998996
Quarters > 3 > ratios > ROE
39.03607013207693
Quarters > 3 > ratios > ROA
-42.16761920654123
Quarters > 3 > ratios > FCF
-5757000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.6968889964895291
Quarters > 3 > health Score
31
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
29431000
Annuals > 0 > income Statement > cost Of Revenue
4103000
Annuals > 0 > income Statement > gross Profit
25328000
Annuals > 0 > income Statement > operating Expenses
65596000
Annuals > 0 > income Statement > operating Income
-36165000
Annuals > 0 > income Statement > interest Expense
3090000
Annuals > 0 > income Statement > pretax Income
-30039000
Annuals > 0 > income Statement > net Income
-30045000
Annuals > 0 > income Statement > eps
-0.960540503766329
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
31279264
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-122.88063606401414
Annuals > 0 > income Statement > total Other Income Expense Net
8812000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
8525000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
5087000
Annuals > 0 > balance Sheet > inventories
4048000
Annuals > 0 > balance Sheet > total Current Assets
20669000
Annuals > 0 > balance Sheet > property Plant Equipment
2879000
Annuals > 0 > balance Sheet > total Assets
23971000
Annuals > 0 > balance Sheet > payables
2274000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
22084000
Annuals > 0 > balance Sheet > total Liabilities
49865000
Annuals > 0 > balance Sheet > equity
-25894000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-30045000
Annuals > 0 > cash Flow > depreciation
744000
Annuals > 0 > cash Flow > change In Working Capital
-9549000
Annuals > 0 > cash Flow > cash From Operations
-40843000
Annuals > 0 > cash Flow > capital Expenditures
345000
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
37936000
Annuals > 0 > cash Flow > net Change In Cash
-3252000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.960540503766329
Annuals > 0 > ratios > PB
-1.9569169568239748
Annuals > 0 > ratios > ROE
116.03074071213409
Annuals > 0 > ratios > ROA
-125.33895123273957
Annuals > 0 > ratios > FCF
-41188000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-1.3994767422105943
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
18511000
Annuals > 1 > income Statement > cost Of Revenue
2605000
Annuals > 1 > income Statement > gross Profit
15906000
Annuals > 1 > income Statement > operating Expenses
72986000
Annuals > 1 > income Statement > operating Income
-54475000
Annuals > 1 > income Statement > interest Expense
16000
Annuals > 1 > income Statement > pretax Income
-59354000
Annuals > 1 > income Statement > net Income
-59363000
Annuals > 1 > income Statement > eps
-2.247473641317321
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
26413213
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-294.28447949867643
Annuals > 1 > income Statement > total Other Income Expense Net
-5294000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
11777000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
3554000
Annuals > 1 > balance Sheet > inventories
2545000
Annuals > 1 > balance Sheet > total Current Assets
20862000
Annuals > 1 > balance Sheet > property Plant Equipment
3270000
Annuals > 1 > balance Sheet > total Assets
24598000
Annuals > 1 > balance Sheet > payables
3391000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
51663000
Annuals > 1 > balance Sheet > equity
-27065000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-63277000
Annuals > 1 > cash Flow > depreciation
702000
Annuals > 1 > cash Flow > change In Working Capital
740000
Annuals > 1 > cash Flow > cash From Operations
-50045000
Annuals > 1 > cash Flow > capital Expenditures
1121000
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
54629000
Annuals > 1 > cash Flow > net Change In Cash
2463000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-2.247473641317321
Annuals > 1 > ratios > PB
-1.5809867009052283
Annuals > 1 > ratios > ROE
219.33493441714393
Annuals > 1 > ratios > ROA
-241.3326286689975
Annuals > 1 > ratios > FCF
-51166000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-2.764086219004916
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
12398000
Annuals > 2 > income Statement > cost Of Revenue
2258000
Annuals > 2 > income Statement > gross Profit
10140000
Annuals > 2 > income Statement > operating Expenses
48837000
Annuals > 2 > income Statement > operating Income
-36439000
Annuals > 2 > income Statement > interest Expense
1000
Annuals > 2 > income Statement > pretax Income
-47178000
Annuals > 2 > income Statement > net Income
-47187000
Annuals > 2 > income Statement > eps
-1.793045255212844
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
26316681
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-46779000
Annuals > 2 > income Statement > operating Margin
-293.91030811421194
Annuals > 2 > income Statement > total Other Income Expense Net
-10918000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
9414000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
1557000
Annuals > 2 > balance Sheet > inventories
1471000
Annuals > 2 > balance Sheet > total Current Assets
17214000
Annuals > 2 > balance Sheet > property Plant Equipment
3612000
Annuals > 2 > balance Sheet > total Assets
21995000
Annuals > 2 > balance Sheet > payables
4947000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
198325000
Annuals > 2 > balance Sheet > equity
-176330000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-47187000
Annuals > 2 > cash Flow > depreciation
398000
Annuals > 2 > cash Flow > change In Working Capital
2300000
Annuals > 2 > cash Flow > cash From Operations
-32313000
Annuals > 2 > cash Flow > capital Expenditures
786000
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
13462000
Annuals > 2 > cash Flow > net Change In Cash
-20637000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-1.793045255212844
Annuals > 2 > ratios > PB
-0.2417797494470595
Annuals > 2 > ratios > ROE
26.760619293370386
Annuals > 2 > ratios > ROA
-214.53512161854968
Annuals > 2 > ratios > FCF
-33099000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-2.669704791095338
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
8401000
Annuals > 3 > income Statement > cost Of Revenue
1193000
Annuals > 3 > income Statement > gross Profit
7208000
Annuals > 3 > income Statement > operating Expenses
32433000
Annuals > 3 > income Statement > operating Income
-24032000
Annuals > 3 > income Statement > interest Expense
1761000
Annuals > 3 > income Statement > pretax Income
-28842000
Annuals > 3 > income Statement > net Income
-28845000
Annuals > 3 > income Statement > eps
-1.0960728672434035
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
26316681
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-26617000
Annuals > 3 > income Statement > operating Margin
-286.0611831924771
Annuals > 3 > income Statement > total Other Income Expense Net
-3049000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
30301000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
1357000
Annuals > 3 > balance Sheet > inventories
1292000
Annuals > 3 > balance Sheet > total Current Assets
35131000
Annuals > 3 > balance Sheet > property Plant Equipment
1797000
Annuals > 3 > balance Sheet > total Assets
37837000
Annuals > 3 > balance Sheet > payables
1300000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
167441000
Annuals > 3 > balance Sheet > equity
-129604000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-28845000
Annuals > 3 > cash Flow > depreciation
464000
Annuals > 3 > cash Flow > change In Working Capital
-131000
Annuals > 3 > cash Flow > cash From Operations
-22697000
Annuals > 3 > cash Flow > capital Expenditures
1258000
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
50768000
Annuals > 3 > cash Flow > net Change In Cash
25813000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-1.0960728672434035
Annuals > 3 > ratios > PB
-0.3289483597728466
Annuals > 3 > ratios > ROE
22.25625752291596
Annuals > 3 > ratios > ROA
-76.2349023442662
Annuals > 3 > ratios > FCF
-23955000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-2.851446256398048
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.21669109076514523
Valuation > metrics > PB
-2.5519702800000004
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
40.45275958840037
Profitability > metrics > ROA
-32.43819011041767
Profitability > metrics > Net Margin
-0.9347224623897631
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-6.173972602739726
Risk > final Score
5
Risk > verdict
High
Liquidity > metrics > Current Ratio
8.807610993657505
Liquidity > metrics > Quick Ratio
7.941860465116279
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
40
Prev Profitabilities > 1
40
Prev Profitabilities > 2
40
Prev Risks > 0
9
Prev Risks > 1
6
Prev Risks > 2
2
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:42:09.081Z
TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers. It offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial for treating locally advanced pancreatic cancer. The company is also developing nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma, intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and pancreatic cancer. It serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. The company was founded in 2009 and is headquartered in Westminster, Colorado.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AHow analysts revise price targets for Izotropic Corporation (1R3) stock - July 2025 Review & Stepwise Trade Signal Guides bollywoodhelpline.com
Read more →Portfolio Update: Is ARTV forming higher highs and higher lows - Global Markets & Trade Opportunity Analysis baoquankhu1.vn
Read more →Showing 2 of 9
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of TriSalus Life Sciences Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.